Thymalfasin: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Pregnancy Category (US FDA) Action Storage CIMS Class

This information is not country-specific. Please refer to the India prescribing information.

Full Generic Medicine Info

Dosage/Direction for Use

Subcutaneous
Chronic hepatitis C, Chronic hepatitis B
Adult: 1.6 mg twice wkly, up to 12 mth; for patients <40 kg: 40 mcg/kg. To be used alone or with interferon for chronic hepatitis B; and with interferon for chronic hepatitis C.

Contraindications

Patients who are deliberately immunosuppressed e.g. organ transplant patients.

Special Precautions

Caution when used with other immunomodulating drugs.

Adverse Reactions

Local discomfort at the inj site, erythema, transient muscle atrophy, rash, polyarthralgia with hand oedema.

Pregnancy Category (US FDA)

Action

Thymalfasin is a thymus hormone. It exerts its immunomodulating effects mainly by enhancing the T cell activity. It may be used alone or with interferon as an immunomodulator for the treatment of chronic hepatitis B and C.
Excretion: Half-life: About 2 hr.

Storage

Subcutaneous: Store between 2-8°C. Reconstituted inj should be used immediately.

CIMS Class

Other Drugs Affecting Hormonal Regulation

Disclaimer: This information is independently developed by CIMS based on thymalfasin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com